Cytokinetics Stock Future Price Prediction

CYTK
 Stock
  

USD 41.00  1.71  4.35%   

Cytokinetics stock price prediction is an act of determining the future value of Cytokinetics shares using few different conventional methods such as EPS estimation, analyst consensus, or fundamental intrinsic valuation. The successful prediction of Cytokinetics' future price could yield a significant profit. Please, note that this module is not intended to be used solely to calculate an intrinsic value of Cytokinetics and does not consider all of the tangible or intangible factors available from Cytokinetics' fundamental data. We analyze noise-free headlines and recent hype associated with Cytokinetics, which may create opportunities for some arbitrage if properly timed.
Continue to Cytokinetics Basic Forecasting Models to cross-verify your projections.
  
Refresh
It is a matter of debate whether stock price prediction based on information in financial news can generate a strong buy or sell signal. We use our internally-built news screening methodology to estimate the value of Cytokinetics based on different types of headlines from major news networks to social media. The Cytokinetics stock price prediction module provides an analysis of price elasticity to changes in media outlook on Cytokinetics over a specific investment horizon.
EPS Estimate Current Year
-4.38
EPS Estimate Next Year
-4.28
Wall Street Target Price
61.58
EPS Estimate Current Quarter
-0.94
Quarterly Revenue Growth YOY
-0.82
Using Cytokinetics hype-based prediction, you can estimate the value of Cytokinetics from the perspective of Cytokinetics response to recently generated media hype and the effects of current headlines on its competitors. We also analyze overall investor sentiment towards Cytokinetics using Cytokinetics' options and short interest. It helps to benchmark the overall future attitude of investors towards Cytokinetics using crowd psychology based on the activity and movement of Cytokinetics' stock price.
Cytokinetics Revenue to Assets are decreasing as compared to previous years. The last year's value of Revenue to Assets was reported at 0.08. The current Total Assets Per Share is estimated to increase to 10.71, while Cash and Equivalents Turnover is projected to decrease to 0.67.

Cytokinetics Implied Volatility

    
  95.75  
Cytokinetics' implied volatility exposes the market's sentiment of Cytokinetics stock's possible movements over time. However, it does not forecast the overall direction of its price. In a nutshell, if Cytokinetics' implied volatility is high, the market thinks the stock has potential for high price swings in either direction. On the other hand, the low implied volatility suggests that Cytokinetics stock will not fluctuate a lot when Cytokinetics' options are near their expiration.
This module is based on analyzing investor sentiment around taking a position in Cytokinetics. This speculative approach is based exclusively on the idea that markets are driven by emotions such as investor fear and greed. The fear of missing out, i.e., FOMO, can cause potential investors in Cytokinetics to buy its stock at a price that has no basis in reality. In that case, they are not buying Cytokinetics because the equity is a good investment, but because they need to do something to avoid the feeling of missing out. On the other hand, investors will often sell stocks at prices well below their value during bear markets because they need to stop feeling the pain of losing money.

Cytokinetics after-hype prediction price

    
  $ 40.62  
There is no one specific way to measure market sentiment using hype analysis or a similar predictive technique. This prediction method should be used in combination with more fundamental and traditional techniques such as stock price forecasting, technical analysis, analysts consensus, earnings estimates, and various momentum models.
Sophisticated investors, who have witnessed many market ups and downs, frequently view the market will even out over time. This tendency of Cytokinetics' price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy. Please use the tools below to analyze the current value of Cytokinetics in the context of predictive analytics.
Intrinsic
Valuation
LowReal ValueHigh
40.0245.0150.00
Details
Naive
Forecast
LowNext ValueHigh
36.4741.4646.45
Details
11 Analysts
Consensus
LowTarget PriceHigh
40.0054.6775.00
Details
Earnings
Estimates (8)
LowProjected EPSHigh
-3.44-3.23-2.91
Details
Please note, it is not enough to conduct a financial or market analysis of a single entity such as Cytokinetics. Your research has to be compared to or analyzed against Cytokinetics' peers to derive any actionable benefits. When done correctly, Cytokinetics' competitive analysis will give you plenty of quantitative and qualitative data to validate your investment decisions or develop an entirely new strategy towards taking a position in Cytokinetics.

Cytokinetics After-Hype Price Prediction Density Analysis

As far as predicting the price of Cytokinetics at your current risk attitude, this probability distribution graph shows the chance that the prediction will fall between or within a specific range. We use this chart to confirm that your returns on investing in Cytokinetics or, for that matter, your successful expectations of its future price, cannot be replicated consistently. Please note, a large amount of money has been lost over the years by many smart people who confused the symmetrical distributions of stock prices, such as prices of Cytokinetics, with the unreliable approximations that try to describe financial returns.
 Next price density 
      Expected price to next headline 

Cytokinetics Estimiated After-Hype Price Volatility

In the context of predicting Cytokinetics' stock value on the day after the next significant headline, we show statistically significant boundaries of downside and upside scenarios based on Cytokinetics' historical news coverage. Cytokinetics' after-hype downside and upside margins for the prediction period are 35.63 and 45.61, respectively. We have considered Cytokinetics' daily market price in relation to the headlines to evaluate this method's predictive performance. Remember, however, there is no scientific proof or empirical evidence that news-based prediction models outperform traditional linear, nonlinear models or artificial intelligence models to provide accurate predictions consistently.
Current Value 41.00
40.62
After-hype Price
45.61
Upside
Cytokinetics is very steady asset. Analysis and calculation of next after-hype price of Cytokinetics is based on 3 months time horizon.

Cytokinetics Stock Price Prediction Analysis

Have you ever been surprised when a price of a company such as Cytokinetics is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading Cytokinetics backward and forwards among themselves. Have you ever observed a lot of a particular company's price movement is driven by press releases or news about the company that has nothing to do with actual earnings? Usually, hype to individual companies acts as price momentum. If not enough favorable publicity is forthcoming, the stock price eventually runs out of speed. So, the rule of thumb here is that as long as this news hype has nothing to do with immediate earnings, you should pay more attention to it. If you see this tendency with Cytokinetics, there might be something going there, and it might present an excellent short sale opportunity.
Expected ReturnPeriod VolatilityHype ElasticityRelated ElasticityNews DensityRelated DensityExpected Hype
 0.16  4.99   0.38   0.16  9 Events / Month0 Events / MonthIn about 9 days
Latest traded priceExpected after-news pricePotential return on next major newsAverage after-hype volatility
41.0040.620.93 
210.55  

Cytokinetics Hype Timeline

Cytokinetics is currently traded for 41.00. The entity has historical hype elasticity of -0.38 and average elasticity to hype of competition of 0.16. Cytokinetics is anticipated to decline in value after the next headline with price expected to drop to 40.62. The average volatility ofmedia hypeimpact on the company stock price is over 100%. The price decrease on the next newsis expected to be -0.93% whereas the daily expected return is currently at 0.16%. The volatility of related hype on Cytokinetics is about 489.22% with expected price after next announcement by competition of 41.16. About 114.0% of the company shares are held by institutions such as insurance companies. The company recorded a loss per share of 3.11. Cytokinetics had not issued any dividends in recent years. The entity had 1:6 split on the 25th of June 2013. Given the investment horizon of 90 days the next anticipatedpress releasewill be in about 9 days.
Continue to Cytokinetics Basic Forecasting Models to cross-verify your projections.

Cytokinetics Related Hype Analysis

Having access to credible news sources related to Cytokinetics' direct competition is more important than ever and may enhance your ability to predict Cytokinetics' future price movements. Getting to know how Cytokinetics rivals react to changing market sentiment, related social signals, and mainstream news is a great way to find investing opportunities and time the market. The summary table below summarizes the essential lagging indicators that can help you analyze how Cytokinetics may potentially react to the hype associated with one of its peers.
Hype
Elasticity
News
Density
Semi
Deviation
Information
Ratio
Potential
Upside
Value
At Risk
Maximum
Drawdown
MMM3M Company 1.02 7 per month 0.00 (0.0309)  2.17 (2.52)  8.68 

Cytokinetics Additional Predictive Modules

Most predictive techniques to examine Cytokinetics price help traders to determine how to time the market. We provide a combination of tools to recognize potential entry and exit points for Cytokinetics using various technical indicators. When you analyze Cytokinetics charts, please remember that the event formation may indicate an entry point for a short seller, and look at other indicators across different periods to confirm that a breakdown or reversion is likely to occur.

About Cytokinetics Predictive Indicators

The successful prediction of Cytokinetics stock price could yield a significant profit to investors. But is it possible? The efficient-market hypothesis suggests that all published stock prices of traded companies, such as Cytokinetics, already reflect all publicly available information. This academic statement is a fundamental principle of many financial and investing theories used today. However, the typical investor usually disagrees with a 'textbook' version of this hypothesis and continually tries to find mispriced stocks to increase returns. We use internally-developed statistical techniques to arrive at the intrinsic value of Cytokinetics based on analysis of Cytokinetics hews, social hype, general headline patterns, and widely used predictive technical indicators.
We also calculate exposure to Cytokinetics's market risk, different technical and fundamental indicators, relevant financial multiples and ratios, and then comparing them to Cytokinetics's related companies.
 2021 2022 (projected)
Long Term Debt to Equity0.590.56
Interest Coverage7.537.48

Story Coverage note for Cytokinetics

The number of cover stories for Cytokinetics depends on current market conditions and Cytokinetics' risk-adjusted performance over time. The coverage that generates the most noise at a given time depends on the prevailing investment theme that Cytokinetics is classified under. However, while its typical story may have numerous social followers, the rapid visibility can also attract short-sellers, who usually are skeptical about Cytokinetics' long-term prospects. So, having above-average coverage will typically attract above-average short interest, leading to significant price volatility.

Cytokinetics Short Properties

Cytokinetics' future price predictability will typically decrease when Cytokinetics' long traders begin to feel the short-sellers pressure to drive the price lower. The predictive aspect of Cytokinetics often depends not only on the future outlook of the potential Cytokinetics' investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. Cytokinetics' indicators that are reflective of the short sentiment are summarized in the table below.
Shares Percent Shares Out9.36%
Short Percent Of Float13.54%
Float Shares84.13M
Shares Short Prior Month7.5M
Average Daily Volume Last 10 Day1.04M
Average Daily Volume In Three Month884.41k
Date Short Interest29th of April 2022
Continue to Cytokinetics Basic Forecasting Models to cross-verify your projections. Note that the Cytokinetics information on this page should be used as a complementary analysis to other Cytokinetics' statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try Analyst Recommendations module to analyst recommendations and target price estimates broken down by several categories.

Complementary Tools for Cytokinetics Stock analysis

When running Cytokinetics price analysis, check to measure Cytokinetics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Cytokinetics is operating at the current time. Most of Cytokinetics' value examination focuses on studying past and present price action to predict the probability of Cytokinetics' future price movements. You can analyze the entity against its peers and financial market as a whole to determine factors that move Cytokinetics' price. Additionally, you may evaluate how the addition of Cytokinetics to your portfolios can decrease your overall portfolio volatility.
Bond Analysis
Evaluate and analyze corporate bonds as a potential investment for your portfolios.
Go
Money Flow Index
Determine momentum by analyzing Money Flow Index and other technical indicators
Go
Idea Analyzer
Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas
Go
CEO Directory
Screen CEOs from public companies around the world
Go
Shere Portfolio
Track or share privately all of your investments from the convenience of any device
Go
Commodity Channel Index
Use Commodity Channel Index to analyze current equity momentum
Go
Premium Stories
Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope
Go
Portfolio Manager
State of the art Portfolio Manager to monitor and improve performance of your invested capital
Go
Headlines Timeline
Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity
Go
Aroon Oscillator
Analyze current equity momentum using Aroon Oscillator and other momentum ratios
Go
Fund Screener
Find actively-traded funds from around the world traded on over 30 global exchanges
Go
Pattern Recognition
Use different Pattern Recognition models to time the market across multiple global exchanges
Go
Portfolio Center
All portfolio management and optimization tools to improve performance of your portfolios
Go
Is Cytokinetics' industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Cytokinetics. If investors know Cytokinetics will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Cytokinetics listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Market Capitalization
3.5 B
Quarterly Revenue Growth YOY
-0.82
Return On Assets
-0.19
Return On Equity
-2.8
The market value of Cytokinetics is measured differently than its book value, which is the value of Cytokinetics that is recorded on the company's balance sheet. Investors also form their own opinion of Cytokinetics' value that differs from its market value or its book value, called intrinsic value, which is Cytokinetics' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Cytokinetics' market value can be influenced by many factors that don't directly affect Cytokinetics' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Cytokinetics' value and its price as these two are different measures arrived at by different means. Investors typically determine Cytokinetics value by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Cytokinetics' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.